GCAN - The Greater Cannabis Company, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1192
-0.0000 (-0.01%)
At close: 2:24PM EDT
Stock chart is not supported by your current browser
Previous Close0.1192
Open0.1100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1076 - 0.1213
52 Week Range0.0600 - 0.3400
Volume11,602
Avg. Volume73,660
Market Cap4.205M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0420
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire

    The Greater Cannabis Company Provides Corporate Update to Shareholders

    OTCQB: GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems is pleased to update its shareholders on operational aspects of the business. Over the last few months the Company has been successful in achieving numerous milestones in the advancement of its business strategy, as outlined in this communication. The Company has finalized and executed a definitive agreement with Symtomax, a leading licensed cannabis cultivation company with the largest outdoor grow facilities in Europe.

  • GlobeNewswire

    Greater Cannabis Company Signs letter of intent (LOI) with RST, Inc.

    Greater Cannabis Company (GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, has announced today a letter of intent (LOI) with RST, Inc. RST is a top global manufacturer of private label skin care products with nearly a billion dollars in products sold worldwide, and more than twenty years of success. Under the agreement, RST will integrate Greater Cannabis Company’s proprietary CBD formulation into its skincare products, with both companies targeting distribution of the CBD-infused products developed across their multinational distribution channels.

  • GlobeNewswire

    GREATER CANNABIS COMPANY PARTNERS WITH SYMTOMAX® TO EXPAND ACROSS EUROPE, THE MIDDLE EAST AND AFRICA

    Greater Cannabis Company (GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, today announced it has entered into a letter of agreement (LOI) with European-based Symtomax, a licensed group on medical cannabis cultivation, research and distribution with over 40 years of experience in the medical cannabis industry. Effective immediately, Symtomax will distribute on a white-label basis Greater Cannabis Company’s oral eluting patch, transdermal patch, and other proprietary technologies and products across its distribution network that spans across Europe, the Middle East and Africa. “Delivering on our commitment to spearhead our expansion plans required an alternative delivery means of legal cannabis. We were drawn to the Greater Cannabis Company’s proprietary and proven technologies, product portfolio and market leadership,” said Paul Segal, Chief Executive Officer of Symtomax.

  • GlobeNewswire

    Greater Cannabis CEO to be Interviewed Today By Cheddar Financial News Live From the New York Stock Exchange

    BALTIMORE, MD, May 01, 2019 (GLOBE NEWSWIRE) --   Greater Cannabis Company (GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, is scheduled to be featured in a live interview today at 1:10 pm EST on the Cheddar Financial News Network on the floor of the New York Stock Exchange (NYSE) during trading hours. During today’s segment, the Company’s Chairman and Chief Executive Officer, Aitan Zacharin, is expected to provide a brief summary of the history of Greater Cannabis Company, why and how it was formed and, in particular, its proprietary cannabinoid delivery system, which is anticipated to become one of the most disruptive technologies in cannabis industry since its legalization.  Please note the interview can be viewed on the Cheddar.tv website and other services the network streams to., which can be found on its site.

  • GlobeNewswire

    GREATER CANNABIS COMPANY LICENSES CBD PATCH TECHNOLOGY TO MAJOR BRAZILIAN RETAIL PHARMACY COMPANY

    The Greater Cannabis Company (GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, today announced it has entered into a letter of agreement (LOI) with a major Brazilian retail pharmacy company, CBR Participacoes SA, to market Greater Cannabis Company’s eluting patch technology for cannabis in Brazil. As part of the agreement, CBR Participacoes will distribute the technology to its network of 300 pharmacies and more than 1,500 point-of-sale retailers in the country, serving the Brazil’s growing demand and market for cannabis products.

  • GlobeNewswire

    Greater Cannabis Company Partners with Allume Cosmeticos To Develop New Cosmetics Line

     BALTIMORE, MD, April 11, 2019 (GLOBE NEWSWIRE) --  Greater Cannabis Company (GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, today announced a letter of agreement (LOI) with leading Brazilian beauty and personal care company Allume Cosmeticos. Under the terms of the agreement, Greater Cannabis Company will customize formulations and incorporate its proprietary technology to infuse pharmaceutical-grade cannabidiol (CBD) into Allume’s new line of CBD-based cosmetic products, empowering Allume to market and distribute CBD-infused beauty and personal care for its retail partners, distributors and millions of customers. CBD has shown multiple beauty and personal care benefits, ranging from antioxidants for anti-aging to anti-inflammatory for acne and other treatments.

  • GlobeNewswire

    The Beauty of CBD: Cannabis Companies Shift Focus towards Beauty and Wellness  

    Investorideas.com, a leading investor news resource covering cannabis stocks, releases a snapshot looking at the many cannabis companies looking into the CBD beauty and wellness sector and why this sector is gaining such momentum. According to one report from the GlobalWellnessInstitute, “a wellness mindset is starting to permeate the global consumer consciousness, affecting people’s daily decision-making – whether food purchases, a focus on mental wellness and reducing stress, incorporating movement into daily life, environmental consciousness, or their yearning for connection and happiness,” noted Katherine Johnston, senior research fellow, GWI. This change in mindset combined with growing interest from large retailers, most recently CVS and Walgreens, is making many companies invest in beauty and wellness.

  • GlobeNewswire

    Greater Cannabis Company Announces Expansion Into CBD Cosmetics And Beauty Market

    Greater Cannabis Company (GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, today announced its expansion into the cannabidiol (CBD) beauty, cosmetics and self-care markets. In addition to its highly bioavailable, orally dissolving transmucosal patch, the Company is now formulating and commercializing a new line of products for CBD-infused cosmetics and skincare applications. “Consumer demand for CBD-infused beauty products has prompted major retailers such as Walgreens, Sephora and CVS, and major cosmetic brands like Estee Lauder, to move into this emerging sector,” said Aitan Zacharin, Chief Executive Officer of Greater Cannabis Company.

  • GlobeNewswire

    GREATER CANNABIS TO BEGIN CLINICAL STUDY OF CBD ABSORPTION THROUGH ITS MULTIFUNCTIONAL, MULTILAYER INTRA-ORAL DRUG DELIVERY TECHNOLOGY

    GREATER CANNABIS COMPANY (GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, has announced today that it will launch a new clinical study to determine cannabidiol (CBD) absorption using its patented eluting patch technology. The new study will help drive the continued development and success of its delivery system and expand its commercialization to LPs, consumer product and pharmaceutical companies.

  • GlobeNewswire

    The Greater Cannabis Company Announces Uplisting To New Market Tier

    The Greater Cannabis Company, Inc. (GCAN) (“the Company”), a biopharmaceutical company focused on development and commercialization of innovative delivery systems for the Cannabis market, today announced that shares of its common stock were approved for quotation on the OTCQB® Venture Market. To qualify for this market, companies must meet high financial standards, follow best practice corporate governance, demonstrate compliance with U.S. securities laws and be current in their disclosure. The Company believes that the move to the OTCQB will provide enhanced investor benefits including higher reporting standards, greater access to analyst coverage and news services, and more comprehensive compliance requirements.

  • GlobeNewswire

    Cannabis Companies Expanding Global Footprint; The Greater Cannabis Company Inc. (OTC:GCAN), Aphria, Canopy Growth and AgraFlora Organics

    Investorideas.com, a leading investor news resource covering cannabis stocks releases a snapshot looking at the global expansion of the cannabis industry and the companies looking at new international markets as regulations change. As new international markets being to open, both cannabis giants as well as smaller cannabis technology companies are now making the necessary preparations to enter this international space. The Greater Cannabis Company, Inc. (OTC:GCAN), recently announced that it has entered into a letter of intent with iCAN Cannabis to expand distribution of its eluting patch platform into key global markets.

  • GlobeNewswire

    The Greater Cannabis Company Announces Distribution Agreement With Leading Global Cannabis Company iCAN: Israel Cannabis Ltd.

    The Greater Cannabis Company, Inc. (GCAN) (“the Company”), a biopharmaceutical company focused on development and commercialization of innovative delivery systems for the Cannabis market is pleased to announce that it has entered into a letter of intent with iCAN Cannabis to expand distribution of its eluting patch platform into key global markets. The agreement with iCAN will include commercial ready formulations to meet medical and recreational market demands. Distribution and marketing rights for iCAN will include Israel, Australia, South Africa, Netherlands, South Africa, Mexico, Colombia, Panama, Germany, Austria, Switzerland, Malta, Macedonia, and Portuguese territories.

  • PR Newswire

    The Greater Cannabis Company Announces Distribution Agreement With Leading Global Cannabis Company iCAN: Israel Cannabis Ltd

    The Greater Cannabis Company, Inc. (GCAN) ("the Company"), a biopharmaceutical company focused on development and commercialization of innovative delivery systems for the Cannabis market is pleased to announce that it has entered into a letter of intent with iCAN Cannabis to expand distribution of its eluting patch platform into key global markets. The agreement with iCAN will include commercial ready formulations to meet medical and recreational market demands. Distribution and marketing rights for iCAN will include Israel, Australia, South Africa, Netherlands, South Africa, Mexico, Colombia, Panama, Germany, Austria, Switzerland, Malta, Macedonia, and Portuguese territories.

  • ACCESSWIRE

    Investors Eyeing New Trends in Biopharma & Healthcare: Stocks Heading Higher

    CORAL GABLES, FL / ACCESSWIRE / November 2, 2018 / The recent boom for things like medical marijuana in the UK as well as the rise of healthcare technology have investors interested in new and exciting companies. Recent developments across both sectors have new companies targeting expanded market share. Technology has become a major part of the healthcare industry, as we know it.

  • GlobeNewswire

    Innovative Cannabis Delivery Technologies on the Rise: The Greater Cannabis Company, Inc. (OTC: GCAN), Aphria, Tilray, Aurora and Canopy Growth

    Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks releases a sector snapshot with a focus on new and innovative delivery systems coming to market. Through the month of September, larger Canadian cannabis companies including Aphria Inc. (TSX: APH), which commences trading on the NYSE today (NYSE:APHA), have been investing heavily in new cannabis delivery systems.

  • GlobeNewswire

    The Greater Cannabis Company to Update Shareholders on Corporate Strategy and Developments of Eluting Patch Platform (EPP) for Cannabinoid Use

    The Greater Cannabis Company, Inc. (GCAN) (“the Company”), a biopharmaceutical company focused on development and commercialization of innovative delivery systems for the Cannabis market, would like to update shareholders on its objectives and roadmap to achieving long term success. The Company has completed development and reformulation of its eluting patch (EPP) for cannabinoid use. In preparation for commercializing cannabinoid products, the Company completed extensive testing of its new formulations.